Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products

Journal of Immunoassay and Immunochemistry

Volumn 30, Issue 4, 2009, Pages 386-399

  Choi, Yeong Gon ^a   Lim, Sabina ^a,b  

^a East West Medical Research Institute   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Advanced glycation end products; AGE modified BSA; N (carboxyethyl)lysine; N (carboxymethyl)lysine; Nonenzymatic glycation; Polymerization

Indexed keywords

6 N CARBOXYETHYLLYSINE; 6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; GLUCOSE; IMMUNOGLOBULIN G ANTIBODY; LYSINE; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCTS BOVINE SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCTS-BOVINE SERUM ALBUMIN; ANTIBODY; ARGININE; DRUG DERIVATIVE; N(6) (1 CARBOXYETHYL)LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-(1-CARBOXYETHYL)LYSINE; N(6)-CARBOXYMETHYLLYSINE;

AFFINITY CHROMATOGRAPHY; ARTICLE; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOREACTIVITY; NONENZYMATIC GLYCATION; POLYMERIZATION; PRIORITY JOURNAL; PURIFICATION; STATISTICAL ANALYSIS; WESTERN BLOTTING; ANIMAL; CATTLE; CROSS REACTION; IMMUNOLOGY; METABOLISM; RABBIT;

ANIMALS; ANTIBODIES; ARGININE; CATTLE; CROSS REACTIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; LYSINE; RABBITS; SERUM ALBUMIN, BOVINE;

EID: 70449732843     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810903188136     Document Type: Article

References (22)

1. Ulrich, P.; Cerami, A. Protein glycation, diabetes, and aging. Recent Prog. Horm. Res. 2001, 56, 1-21.
2. Thornalley, P.J.; Langborg, A.; Minhas, H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 1999, 344, 109-116.
3. Brownlee, M.; Cerami, A.; Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 1988, 318, 1315-1321.
4. Cerami, A.; Vlassara, H.; Brownlee, M. Role of nonenzymatic glycosylation in atherogenesis. J. Cell. Biochem. 1986, 30, 111-120.
5. Miyata, T.; Iida, Y.; Horie, K.; Cai, Z.; Sugiyama, S.; Maeda, K. Pathophysiology of advanced glycation end-products in renal failure. Nephrol. Dial. Transplant. 1996, 11 (Suppl 5), 27-30. (Pubitemid 27062907)
6. Bucala, R.; Vlassara, H. Advanced glycosylation end products in diabetic renal and vascular disease. Am. J. Kidney Dis. 1995, 26, 875-888.
7. Thorpe, S.R.; Baynes, J.W. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 1996, 9, 69-77.
8. Ikeda, K.; Higashi, T.; Sano, H.; Jinnouchi, Y.; Yoshida, M.; Araki, T.; Ueda, S.; Horiuchi, S. Ne-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996, 35, 8075-8083.
9. Yoshida, S.; Yamada, K.; Hamaguchi, K.; Nishimura, M.; Hatakeyama, E.; Tsuchida, H.; Sakamoto, K.; Kashiwabara, H.; Yokoyama, T.; Ikeda, K.; Horiuchi, S. Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation. Clin. Nephrol. 1998, 49, 273-280.
10. Horiuchi, S.; Araki, N.; Morino, Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J. Biol. Chem. 1991, 266, 7329-7332.
11. Makita, Z.; Vlassara, H.; Cerami, A.; Bucala, R. Immunochemical detection of advanced glycosylation end products in vivo. J. Biol. Chem. 1992, 267, 5133-5138.
12. Koito, W.; Araki, T.; Horiuchi, S.; Nagai, R. Conventional antibody against Ne-(carboxymethyl)lysine (CML) shows cross-reaction to Ne-(carboxyethyl)- lysine (CEL): immunochemical quantification of CML with a specific antibody. J. Biochem. 2004, 136, 831-837.
13. Nagai, R.; Fujiwara, Y.; Mera, K.; Yamagata, K.; Sakashita, N.; Takeya, M. Immunochemical detection of Ne-(carboxyethyl)lysine using a specific antibody. J. Immunol. Methods 2008, 332, 112-120.
14. Nagai, R.; Fujiwara, Y.; Mera, K.; Motomura, K.; Iwao, Y.; Tsurushima, K.; Nagai, M.; Takeo, K.; Yoshitomi, M.; Otagiri, M.; Ikeda, T. Usefulness of antibodies for evaluating the biological significance of AGEs. Ann. N. Y. Acad. Sci. 2008, 1126, 38-41.
15. Nagai, R.; Araki, T.; Hayashi, C.M.; Hayase, F.; Horiuchi, S. Identification of Ne-(carboxyethyl)lysine, one of the methylglyoxal-derived AGE structures, in glucose-modified protein: Mechanism for protein modification by reactive aldehydes. J. Chromatogr. B.: Analyt. Technol. Biomed. Life Sci. 2003, 788, 75-84.
16. Burrer, R.; Haessig-Einius, S.; Aubertin, A.M.; Moog, C. Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells. J. Virol. 2003, 77, 11385-11397.
17. Ahaded, A.; Brossard, Y.; Debbia, M.; Lambin, P. Quantitative determination of anti-K (KEL1) IgG and IgG subclasses in the serum of severely alloimmunized pregnant women by ELISA. Transfusion 2000, 40, 1239-1245.
18. Takeuchi, M.; Makita, Z. Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo. Curr. Mol. Med. 2001, 1, 305-315.
19. Baynes, J.W. The role of AGEs in aging: Causation or correlation. Exp. Gerontol. 2001, 36, 1527-1537.
20. Friess, U.; Waldner, M.; Wahl, H.G.; Lehmann, R.; Haring, H.U.; Voelter, W.; Schleicher, E. Liquid chromatography-based determination of urinary free and total Ne-(carboxymethyl)lysine excretion in normal and diabetic subjects. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2003, 794, 273-280.
21. Misselwitz, J.; Franke, S.; Kauf, E.; John, U.; Stein, G. Advanced glycation end products in children with chronic renal failure and type 1 diabetes. Pediatr. Nephrol. 2002, 17, 316-321.
22. Degenhardt, T.P.; Grass, L.; Reddy, S.; Thorpe, S.R.; Diamandis, E.P.; Baynes, J.W. Technical note. The serum concentration of the advanced glycation end-product Ne-(carboxymethyl)lysine is increased in uremia. Kidney Int. 1997, 52, 1064-1067.